{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T01:39:00Z","timestamp":1777081140094,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.vaccine.2019.02.037","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T18:36:15Z","timestamp":1553193375000},"page":"2387-2393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9872-2313","authenticated-orcid":false,"given":"Kyla","family":"Hayford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Mutembo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Carcelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hellen K.","family":"Matakala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Passwell","family":"Munachoonga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane W.","family":"Wanyiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Searle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis D.","family":"Mwansa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angels","family":"Mwiche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Phiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Book","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip E.","family":"Thuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6579-3513","authenticated-orcid":false,"given":"William J.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2019.02.037_b0005","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1586\/14760584.2013.814847","article-title":"Measles elimination: progress, challenges and implications for rubella control","volume":"12","author":"Cutts","year":"2013","journal-title":"Exp Rev Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2019.02.037_b0010","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1590\/S1020-49892004001200013","article-title":"Assessing and monitoring vaccination coverage levels: lessons from the Americas","volume":"16","author":"Dietz","year":"2004","journal-title":"Rev Panam Salud Publica"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.02.037_b0015","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1086\/368052","article-title":"Use of administrative data to estimate mass vaccination campaign coverage, Burkina Faso, 1999","volume":"187","author":"Zuber","year":"2003","journal-title":"J Infect Dis"},{"issue":"9655","key":"10.1016\/j.vaccine.2019.02.037_b0020","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(08)61869-3","article-title":"Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage","volume":"372","author":"Lim","year":"2008","journal-title":"Lancet"},{"issue":"35","key":"10.1016\/j.vaccine.2019.02.037_b0025","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1016\/j.vaccine.2016.06.053","article-title":"Monitoring vaccination coverage: defining the role of surveys","volume":"34","author":"Cutts","year":"2016","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2019.02.037_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127105","article-title":"Cluster survey evaluation of a measles vaccination campaign in Jharkhand, India, 2012","volume":"10","author":"Scobie","year":"2015","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.vaccine.2019.02.037_b0035","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2471\/BLT.07.045328","article-title":"Use and abuse of rapid monitoring to assess coverage during mass vaccination campaigns","volume":"85","author":"Luman","year":"2007","journal-title":"Bull World Health Org"},{"issue":"19","key":"10.1016\/j.vaccine.2019.02.037_b0040","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/j.vaccine.2008.10.002","article-title":"Estimating vaccination coverage: validity of household-retained vaccination cards and parental recall","volume":"27","author":"Luman","year":"2009","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2019.02.037_b0045","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S1473-3099(17)30421-8","article-title":"Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis","volume":"17","author":"Trentini","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2019.02.037_b0050","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/tmi.12737","article-title":"Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries","volume":"21","author":"Cutts","year":"2016","journal-title":"Trop Med Int Health"},{"issue":"10045","key":"10.1016\/j.vaccine.2019.02.037_b0055","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0140-6736(16)30164-7","article-title":"Use of serological surveys to generate key insights into the changing global landscape of infectious disease","volume":"388","author":"Metcalf","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.037_b0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/infdis\/jiy137","article-title":"Benefits and challenges in using seroprevalence data to inform models for measles and rubella elimination","volume":"218","author":"Winter","year":"2018","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.037_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149970","article-title":"Immunization coverage surveys and linked biomarker serosurveys in three regions in Ethiopia","volume":"11","author":"Travassos","year":"2016","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2019.02.037_b0070","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.4269\/ajtmh.18-0320","article-title":"Integrating blood collection within household surveys: lessons learned from nesting a measles and rubella serological survey within a post-campaign coverage evaluation survey in Southern Province, Zambia","volume":"99","author":"Mutembo","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.02.037_b0075","series-title":"Vaccination coverage cluster surveys: reference manual","author":"WHO","year":"2018"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.037_b0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/INF.0000000000001422","article-title":"Measles and rubella seroprevalence among HIV-infected and uninfected Zambian youth","volume":"36","author":"Sutcliffe","year":"2017","journal-title":"Pediatric Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.02.037_b0085","series-title":"The immunological basis for immunization series. Module 7: measles \u2013 update 2009","author":"Moss","year":"2009"},{"key":"10.1016\/j.vaccine.2019.02.037_b0090","unstructured":"WHO. Measles cases, country slides; 2018. http:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/vpd\/surveillance_type\/Country_slides_measles.pdf."},{"issue":"7223","key":"10.1016\/j.vaccine.2019.02.037_b0095","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1136\/bmj.319.7223.1462","article-title":"Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review","volume":"319","author":"Panagiotopoulos","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2019.02.037_b0100","article-title":"Congenital rubella syndrome surveillance in South Africa using a sentinel site approach: a cross-sectional study","author":"Motaze","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.037_b0105","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijid.2016.05.009","article-title":"Rubella immunity among pregnant women aged 15\u201344 years, Namibia, 2010","volume":"49","author":"Jonas","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.037_b0110","unstructured":"Gavi. Gavi, the vaccine alliance. Countries approved for support. https:\/\/www.gavi.org\/results\/countries-approved-for-support [accessed September 10, 2018]."},{"issue":"28","key":"10.1016\/j.vaccine.2019.02.037_b0115","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1016\/j.vaccine.2018.04.036","article-title":"Assessing population immunity for measles elimination \u2013 the promise and peril of serosurveys","volume":"36","author":"Durrheim","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.037_b0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcv.2015.11.022","article-title":"Performance of 14 rubella IgG immunoassays on samples with low positive or negative haemagglutination inhibition results","volume":"74","author":"Huzly","year":"2016","journal-title":"J Clin Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2019.02.037_b0125","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1128\/JCM.00231-08","article-title":"Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter","volume":"46","author":"Dimech","year":"2008","journal-title":"J Clin Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:32:12Z","timestamp":1759401132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19302427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":25,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0264410X19302427"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}